Department of Otorhinolaryngology Head and Neck Surgery, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.
Institute of Translational Medicine, Zhejiang Shuren University, Hangzhou, 310015, Zhejiang, China.
J Nanobiotechnology. 2024 Jan 28;22(1):41. doi: 10.1186/s12951-024-02298-7.
Malignancy is a major public health problem and among the leading lethal diseases worldwide. Although the current tumor treatment methods have therapeutic effect to a certain extent, they still have some shortcomings such as poor water solubility, short half-life, local and systemic toxicity. Therefore, how to deliver therapeutic agent so as to realize safe and effective anti-tumor therapy become a problem urgently to be solved in this field. As a medium of information exchange and material transport between cells, exosomes are considered to be a promising drug delivery carrier due to their nano-size, good biocompatibility, natural targeting, and easy modification. In this review, we summarize recent advances in the isolation, identification, drug loading, and modification of exosomes as drug carriers for tumor therapy alongside their application in tumor therapy. Basic knowledge of exosomes, such as their biogenesis, sources, and characterization methods, is also introduced herein. In addition, challenges related to the use of exosomes as drug delivery vehicles are discussed, along with future trends. This review provides a scientific basis for the application of exosome delivery systems in oncological therapy.
恶性肿瘤是一个重大的公共卫生问题,也是全球主要致死疾病之一。尽管目前的肿瘤治疗方法在一定程度上具有治疗效果,但它们仍然存在一些缺点,如水溶性差、半衰期短、局部和全身毒性。因此,如何输送治疗剂以实现安全有效的抗肿瘤治疗成为该领域亟待解决的问题。外泌体作为细胞间信息交换和物质运输的介质,由于其纳米尺寸、良好的生物相容性、天然靶向性和易于修饰等特点,被认为是一种很有前途的药物载体。本文综述了近年来作为肿瘤治疗药物载体的外泌体的分离、鉴定、药物装载和修饰及其在肿瘤治疗中的应用的最新进展。本文还介绍了外泌体的基本知识,如它们的生物发生、来源和表征方法。此外,还讨论了外泌体作为药物载体使用的相关挑战以及未来的发展趋势。本综述为外泌体递送系统在肿瘤治疗中的应用提供了科学依据。
J Nanobiotechnology. 2024-1-28
J Mater Chem B. 2023-11-15
Crit Rev Oncol Hematol. 2022-4
Biochem Pharmacol. 2023-9
Cancer Lett. 2023-4-1
J Nanobiotechnology. 2022-6-14
Eur J Pharm Biopharm. 2020-9
Theranostics. 2019-1-30
Invest New Drugs. 2025-9-4
Mater Today Bio. 2025-8-5
Clin Med Insights Oncol. 2025-8-10
Int J Biol Sci. 2025-6-5
Stem Cell Res Ther. 2025-5-28
Int J Mol Sci. 2025-5-19
Biomater Res. 2025-5-9
Plants (Basel). 2023-3-7
Pharmaceuticals (Basel). 2023-3-10
J Nanobiotechnology. 2023-3-29
Signal Transduct Target Ther. 2023-3-15
Pharmaceutics. 2023-1-30
Pharmaceutics. 2023-1-21